Crescent Biopharma to Present at September Investor Conferences
Crescent Biopharma plans September 2026 fireside chats at Cantor and Morgan Stanley investor healthcare conferences, with webcasts and 90-day replays available.
Rhea-AI Summary
Crescent Biopharma (CBIO)/b) will present at two September 2026 investor conferences via fireside chats in New York.Management is scheduled for the 2026 Cantor Global Healthcare Conference on Thursday, September 10, 2026 at 1:35 p.m. ET and the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 5:35 p.m. ET. Live webcasts and 90-day replays will be available in the Investors section of the company website.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 03 | Inducement awards | Neutral | +2.8% | Equity inducement awards for one non-executive employee |
| Jul 30 | Q2 earnings report | Positive | +1.7% | Cash runway update and oncology pipeline progress |
| Jul 23 | Inducement awards | Neutral | -4.3% | Equity inducement awards for two non-executive employees |
| Jul 16 | Public offering closing | Negative | -2.4% | Ordinary shares and pre-funded warrants issued in completed offering |
| Jul 14 | Public offering pricing | Negative | +2.4% | Offering priced at $14.50 per ordinary share |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Historical reactions were mixed, with positive responses to some announcements and divergent reactions to the two July offering announcements.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that management is scheduled to present at the following investor conferences in September:
- 2026 Cantor Global Healthcare Conference, fireside chat on Thursday, September 10, 2026 at 1:35 p.m. ET in New York.
- Morgan Stanley 24th Annual Global Healthcare Conference, fireside chat on Monday, September 14, 2026 at 5:35 p.m. ET in New York.
A live webcast of each presentation will be available in the Investors section of the Company's website at https://investors.crescentbiopharma.com/events-presentations, and a replay will be accessible for 90 days.
About Crescent Biopharma
Crescent Biopharma’s vision is to build a world leading oncology company bringing the next wave of therapies for cancer patients. The Company’s clinical-stage pipeline includes its lead program, a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates (ADCs). By leveraging multiple modalities and established targets, Crescent aims to rapidly advance potentially transformative therapies as single agents and as part of combination regimens to treat a range of solid tumors. For more information, visit www.crescentbiopharma.com and follow the Company on LinkedIn and X.
Contacts
Investors
Amy Reilly
Chief Communications Officer
amy.reilly@crescentbiopharma.com
617-465-0586
Media
Jenna Poist
Director, Corporate Communications
jenna.poist@crescentbiopharma.com
781-671-5019
